Bio-Techne Corp.
Charles R. Kummeth, CEO
Exercised options: 38,118Price: $67.46
Shares sold: 38,118Price: $217.28-$221.13
Date: Jan. 2-6Directly holds: 130,189
Calyxt Inc.
Philippe Dumont, director
Shares sold: 236Price: $7.60
Bio-Techne Corp.
Charles R. Kummeth, CEO
Exercised options: 38,118Price: $67.46
Shares sold: 38,118Price: $217.28-$221.13
Date: Jan. 2-6Directly holds: 130,189
Calyxt Inc.
Philippe Dumont, director
Shares sold: 236Price: $7.60
Date: Jan. 3Directly holds: 1,762
Anna Kozicz-Stankiewicz, director
Shares sold: 245Price: $7.65
Date: Jan. 3Directly holds: 3,655
Donaldson Co. Inc.
Amy C. Becker, officer
Exercised options: 6,000Price: $21.14
Date: Jan. 2Directly holds: na
Surmodics Inc.
Gary R. Maharaj, CEO
Shares sold: 702Price: $41.08
Date: Jan. 2Directly holds: 142,885
Tactile Systems Technology Inc.
Gerald R. Mattys, CEO
Exercised options: 25,000Price: $0.96
Date: Dec. 31Directly holds: na
Tennant Co.
Hans Chris Killingstad, CEO
Exercised options: 12,843Price: $24.21
Shares sold: 12,843Price: $77.65–$77.89
Date: Jan. 2Directly holds: 158,911
Winmark Corp.
Ronald G. Olson, beneficial owner
Shares sold: 5,000Price: $198.32
Date: Jan. 6Directly holds: 398,311
The U.S. stock market roared back on Friday, as technology stocks recovered much of their losses from earlier in the week and bitcoin halted its plunge, at least for now.